Published in Acta Paediatr on February 01, 1997
New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev (2012) 2.01
Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care (1999) 1.81
Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed (2004) 1.54
Early-onset neonatal sepsis. Clin Microbiol Rev (2014) 1.53
Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J Surg (2005) 1.51
Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis. Eur J Pediatr (2008) 1.46
Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child (1999) 1.30
Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther (2011) 1.27
Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatr (2006) 0.98
Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci (2012) 0.96
Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed (2006) 0.93
Procalcitonin in preoperative diagnosis of abdominal sepsis. Langenbecks Arch Surg (2007) 0.92
Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr (2007) 0.87
Serum procalcitonin in viral and bacterial meningitis. J Glob Infect Dis (2011) 0.86
Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis. Mediators Inflamm (2004) 0.84
Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Pediatr (2014) 0.83
Which biomarkers reveal neonatal sepsis? PLoS One (2013) 0.83
Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis. Exp Ther Med (2014) 0.80
Early-Onset Neonatal Sepsis: Still Room for Improvement in Procalcitonin Diagnostic Accuracy Studies. Medicine (Baltimore) (2015) 0.77
The use of procalcitonin as a marker of sepsis in children. J Clin Diagn Res (2013) 0.77
Amalgamation of procalcitonin, C-reactive protein, and sequential organ failure scoring system in predicting sepsis survival. Anesth Essays Res (2015) 0.77
Utility of cytokine, adhesion molecule and acute phase proteins in early diagnosis of neonatal sepsis. J Nat Sci Biol Med (2017) 0.77
Age-specific percentile-based reference curve of serum procalcitonin concentrations in Japanese preterm infants. Sci Rep (2016) 0.75
Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr (2010) 4.32
Marked improvement of the basophil activation test by detecting CD203c instead of CD63. Clin Exp Allergy (2003) 2.45
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis (2006) 1.67
Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells. Cytokine (2000) 1.55
Diet, fat accretion, and growth in premature infants. N Engl J Med (1981) 1.45
Net calcium absorption in premature infants: results of 103 metabolic balance studies. Am J Clin Nutr (1992) 1.41
[Feeding of infants based on age. Practice guidelines]. Arch Pediatr (2003) 1.40
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood (1998) 1.36
Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency. J Investig Allergol Clin Immunol (2011) 1.34
Conserved composition of mammalian box H/ACA and box C/D small nucleolar ribonucleoprotein particles and their interaction with the common factor Nopp140. Mol Biol Cell (2000) 1.29
Procalcitonin as an acute phase marker. Ann Clin Biochem (2001) 1.27
Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet (1998) 1.26
Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Arch Allergy Immunol (2008) 1.20
Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer (2000) 1.17
Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest (1994) 1.16
Nutrient balance, energy utilization, and composition of weight gain in very-low-birth-weight infants fed pooled human milk or a preterm formula. J Pediatr (1984) 1.15
Effects of vitamin D and phosphorus supplementation on calcium retention in preterm infants fed banked human milk. J Pediatr (1983) 1.11
Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis (2000) 1.08
Cytokine and hormonal changes after cholecystectomy. Effect of ibuprofen pretreatment. Ann Surg (1996) 1.04
Nuclear DNA origin of mitochondrial complex I deficiency in fatal infantile lactic acidosis evidenced by transnuclear complementation of cultured fibroblasts. J Clin Invest (1999) 1.04
Detection and quantification of drug-specific T cells in penicillin allergy. Allergy (2009) 1.03
Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. II. Technical issues. J Investig Allergol Clin Immunol (2008) 1.03
Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab (1981) 1.03
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol (1997) 1.02
Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial. Hum Gene Ther (1997) 1.02
Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii. Clin Diagn Lab Immunol (2002) 1.01
[Quality specifications and allowable standards for validation of methods used in clinical biochemistry]. Ann Biol Clin (Paris) (1999) 1.01
[Respiratory arrest in the delivery room while lying in the prone position on the mothers' chest in 11 full term healthy neonates]. Arch Pediatr (2006) 0.99
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun (1999) 0.97
Evolution of serum prealbumin, C-reactive protein, and orosomucoid in neonates with bacterial infection. J Pediatr (1984) 0.97
Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments. Physiol Genomics (2011) 0.96
Effects of calcium and phosphorus supplementation on calcium retention and fat absorption in preterm infants fed pooled human milk. J Pediatr Gastroenterol Nutr (1986) 0.95
New international reference preparation for proteins in human serum (RPPHS). Clin Chem (1994) 0.95
Dietary composition and macronutrient storage in preterm infants. Pediatrics (1983) 0.94
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults. Eur J Endocrinol (2007) 0.93
Regional chemotherapy (with mitomycin C) and intra-operative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology (1994) 0.93
Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study. Anticancer Res (1999) 0.92
Increased production of a Th2 cytokine profile by activated whole blood cells from rheumatoid arthritis patients. J Clin Immunol (1998) 0.92
Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: role of the tumor necrosis factor ligand-receptor system. J Clin Oncol (2000) 0.92
Increased serum procalcitonin levels are not specific to sepsis in neonates. Clin Infect Dis (1998) 0.92
Elevated circulating levels of TNFalpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Haematol (1996) 0.91
Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus (2010) 0.91
Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Eur Cytokine Netw (1995) 0.91
A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French family. Arthritis Rheum (2000) 0.89
[Infants born to kidney transplant recipients]. Arch Fr Pediatr (1991) 0.87
Human gammadelta T cells express a higher TCR/CD3 complex density than alphabeta T cells. Clin Immunol (2001) 0.87
Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med (1999) 0.87
Partition of energy metabolism and energy cost of growth in the very low-birth-weight infant. Pediatrics (1982) 0.87
Quality of growth in premature infants fed their own mothers' milk. J Pediatr (1983) 0.86
Drug-induced urticaria. Eur J Dermatol (2001) 0.86
LPS increases biomaterial degradation by human monocytes in vitro. J Biomed Mater Res (1997) 0.86
Metabolic and energy balance in small- and appropriate-for-gestational-age, very low-birth-weight infants. Acta Paediatr Suppl (1994) 0.86
Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones. Allergy (2009) 0.85
Metabolic consequences of intrauterine growth retardation in very low birthweight infants. Pediatr Res (1984) 0.85
Usefulness of the prognostic inflammatory and nutritional index (PINI) in hospitalized elderly patients. Int J Vitam Nutr Res (1998) 0.85
Laboratory data in healthy volunteers: reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials. Eur J Clin Pharmacol (1999) 0.85
Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis. Infection (1998) 0.84
Nutritional evaluation of protein hydrolysate formulas. Eur J Clin Nutr (1995) 0.84
[Supplementary parenteral nutrition in premature infants. Adaptation to amino acid intake]. Arch Fr Pediatr (1987) 0.84
Continuous insulin infusion in hyperglycaemic very-low-birth-weight infants receiving parenteral nutrition. Clin Nutr (2003) 0.83
[Anaphylactic shock associated with ceftriaxone therapy in a newborn]. Arch Pediatr (2002) 0.83
Detection of allergen-induced basophil activation by expression of CD63 antigen using a tricolour flow cytometric method. Clin Exp Immunol (1999) 0.83
Rapid quantitative procalcitonin measurement to diagnose nosocomial infections in newborn infants. Arch Dis Child Fetal Neonatal Ed (2009) 0.83
Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy. Clin Exp Rheumatol (2008) 0.83
Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides. Cancer Immunol Immunother (1994) 0.83
[Long term renal outcome of children born preterm: a regular follow-up is needed]. Arch Pediatr (2009) 0.82
Leucine kinetics in fed low-birth-weight infants: importance of splanchnic tissues. Am J Physiol (1992) 0.82
Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion. J Cardiovasc Pharmacol (1995) 0.82
Functional hypersomatotropism in small for gestational age (SGA) newborn infants. J Clin Endocrinol Metab (1989) 0.82
Mineral balance and whole body bone mineral content in very low-birth-weight infants. Acta Paediatr Suppl (1994) 0.82
Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients. Exp Hematol (2001) 0.82
Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins. J Autoimmun (1999) 0.82
Influence of postnatal age, energy intake, and weight gain on energy metabolism in the very low-birth-weight infant. J Pediatr (1981) 0.82
Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation. Eur J Clin Pharmacol (2001) 0.81
Study of the pharmacokinetics of mitomycin C in humans during intraperitoneal chemohyperthermia with special mention of the concentration in local tissues. Oncology (1993) 0.81
Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas. Cancer Immunol Immunother (2000) 0.81
Cyclosporin A inhibits dendritic cell maturation promoted by TNF-alpha or LPS but not by double-stranded RNA or CD40L. J Leukoc Biol (2002) 0.81
Procalcitonin as a specific marker of bacterial infection in adults. Clin Chem Lab Med (1998) 0.81
Fas and Fas ligand expression in cystic fibrosis airway epithelium. Thorax (1999) 0.81
Spontaneous otoacoustic emissions in preterm neonates: prevalence and gender effects. Hear Res (1995) 0.81
Procalcitonin is not produced by circulating blood cells. Infection (1999) 0.81
Staphylococcal entertotoxins of the enterotoxin gene cluster (egcSEs) induce nitrous oxide- and cytokine dependent tumor cell apoptosis in a broad panel of human tumor cells. Front Cell Infect Microbiol (2013) 0.80
[Promotion of breast feeding: it's the role of pediatricians...]. Arch Pediatr (2000) 0.80
[Recombinant Human Erythropoietin (r-HuEPO) therapy in a newborn with hereditary spherocytosis]. Arch Pediatr (2003) 0.80
Vitamin D metabolism in preterm infants. Biol Neonate (1987) 0.80
Recommended method for assaying serum zinc with flame atomic absorption. Ann Biol Clin (Paris) (1986) 0.80
Carbohydrate derived energy and gross energy absorption in preterm infants fed human milk or formula. Arch Dis Child (1986) 0.80
Energy substrate utilization in infants receiving total parenteral nutrition with different glucose to fat ratios. Pediatr Res (1989) 0.80
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients. Br J Cancer (1998) 0.80
Treatment of malignant peritoneal effusion in digestive and ovarian cancer. Med Oncol Tumor Pharmacother (1992) 0.80